Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19.

Gonzalo Cabezón VillalbaIgnacio J Amat-SantosCarlos DueñasDiego Lopez OteroPablo CatalaAlvaro AparisiJavier López-PaisCarla Eugenia Cacho AntonioJordi CandelaPablo Antúnez MuiñosJose Francisco GilTeba Gonzalez FerreroMarta MarcosMarta Pérez-PozaGino RojasOscar Otero GarciaCarlos VerasVictor Jiménez RamosAitor UribarriAna RevillaPablo Elpidio Garcia-GranjaItziar GómezJosé Ramón González-JuanateyJosé Alberto San Román

Published in: Cardiology journal (2021)

The presence of HD is related to higher mortality. Cardiovascular medications taken before admission are not harmful, statins being protective. The development of cardiovascular events during the course of the disease is related to poor outcome.

Keyphrases

cardiovascular events
cardiovascular disease
coronary artery disease
coronavirus disease
sars cov
emergency department
pulmonary hypertension